Prospective monitoring of carbapenem use and pseudomonal resistance across pediatric institutions.
Isao MiyairiKensuke ShojiNoriko KinoshitaJunpei SaitohYoshie SugaharaYasushi WatanabeMakoto KomuraMasashi KasaiYuho HorikoshiMasayoshi ShinjohTakashi Igarashinull nullPublished in: Infection control and hospital epidemiology (2020)
Antimicrobial use and resistance, targeting carbapenems and P. aeruginosa, respectively, can serve as benchmarks that can be utilized to promote antimicrobial stewardship across pediatric healthcare institutions.